A non-randomised controlled study 122 looked prospectively at glycated Hb and micro- albuminuria risk in people with Type 1 diabetes attending their clinic. Their data did suggest a threshold effect (small and unchanging incidence below threshold, sharp rise above), at 7.9ï¿½8.5% HbA 1c (the authors chose to centre on 8.1%)
---
 nice.evidencecategory: IIa
[@Krolewski_1995]
